Researchers from the Massachusetts Institute of Technology (MIT) and Harvard Medical School have found a novel way to ...
Chimeric antigen receptor T-cell (CAR-T) therapies have emerged as a revolutionary approach in the field of hematological malignancies, offering unprecedented clinical efficacy when patients have ...
Researchers report the first human test of an enzyme-converted A-type kidney to universal O, which if validated in future ...
Luc Teyton, professor in the Department of Immunology and Microbiology at Scripps Research, has received a five-year, $3.2 ...
Annie Curtis’s research team revealed how circadian rhythm-regulated mitochondrial metabolism drives dendritic cell antigen presentation activity. To activate T cells, DCs take up, process, and ...
The terms “process-specific” and “generic” are commonly used in scientific publications and regulatory guidelines in reference to host cell protein (HCP) analysis of recombinant biopharmaceuticals.